Riik: Iirimaa
keel: inglise
Allikas: HPRA (Health Products Regulatory Authority)
Lamotrigine
Profind Wholesale Ltd
N03AX09
Lamotrigine
25 milligram(s)
Chewable/dispersible tablet
Product subject to prescription which may be renewed (B)
lamotrigine
Authorised
2010-04-23
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lamictal 25mg dispersible/chewable Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each dispersible/chewable tablet contains 25mg lamotrigine. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Dispersible/chewable tablet _Product imported from the UK:_ White to off white square tablet with rounded corners marked ‘GSCL5’ on one side and ‘25’ on the other. The tablets have a blackcurrant odour and may be slightly mottled. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Epilepsy _Adults and adolescents aged 13 years and above_ - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic - clonic seizures. - Seizures associated with Lennox - Gastaut syndrome. Lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox - Gastaut syndrome. _Children and adolescents aged 2 to 12 years_ - Adjunctive treatment of partial seizures and generalised seizures, including tonic - clonic seizures and the seizures associated with Lennox - Gastaut syndrome. - Monotherapy of typical absence seizures. Bipolar disorder _Adults aged 18 years and above_ - Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes (see section 5.1). Lamictal is not indicated for the acute treatment of manic or depressive episodes. I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _8_ _/_ _0_ _5_ _/_ _ Lugege kogu dokumenti